{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,20]],"date-time":"2025-04-20T04:03:01Z","timestamp":1745121781162,"version":"3.40.4"},"reference-count":10,"publisher":"Japanese Society of Internal Medicine","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2025,4,15]]},"DOI":"10.2169\/internalmedicine.4025-24","type":"journal-article","created":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T22:13:04Z","timestamp":1727388784000},"page":"1241-1243","source":"Crossref","is-referenced-by-count":0,"title":["Anti-leucine-rich Glioma-inactivated 1 Encephalitis Manifesting as Frequent Ictal Pouting and Subtle Memory Disturbance"],"prefix":"10.2169","volume":"64","author":[{"given":"Takeshi","family":"Araki","sequence":"first","affiliation":[{"name":"Department of Neurology, Kobe City Medical Center General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hajime","family":"Yoshimura","sequence":"additional","affiliation":[{"name":"Department of Neurology, Kobe City Medical Center General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenta","family":"Tsuchida","sequence":"additional","affiliation":[{"name":"Department of Neurology, Kobe City Medical Center General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriko","family":"Hatanaka","sequence":"additional","affiliation":[{"name":"Department of Neurology, Himeji Central Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michi","family":"Kawamoto","sequence":"additional","affiliation":[{"name":"Department of Neurology, Kobe City Medical Center General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. van Sonderen A, Thijs RD, Coenders EC, et al. Anti-LGI1 encephalitis: clinical syndrome and long-term follow-up. Neurology 87: 1449-1456, 2016.","DOI":"10.1212\/WNL.0000000000003173"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Finke C, Pr\u00fcss H, Heine J, et al. Evaluation of cognitive deficits and structural hippocampal damage in encephalitis with leucine-rich, glioma-inactivated 1 antibodies. JAMA Neurol 74: 50-59, 2017.","DOI":"10.1001\/jamaneurol.2016.4226"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Steriade C, Britton J, Dale RC, et al. Acute symptomatic seizures secondary to autoimmune encephalitis and autoimmune-associated epilepsy: conceptual definitions. Review Epilepsia 61: 1341-1351, 2020.","DOI":"10.1111\/epi.16571"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Souirti Z, Landr\u00e9 E, Mellerio C, et al. Neural network underlying ictal pouting ("chapeau de gendarme") in frontal lobe epilepsy. Epilepsy Behav 37: 249-257, 2014.","DOI":"10.1016\/j.yebeh.2014.07.009"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Lu H, Zhang W, Liu S, et al. The chapeau de gendarme sign can be evoked by lateral prefrontal epileptic seizures. Seizure 87: 17-20, 2021.","DOI":"10.1016\/j.seizure.2021.02.024"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Shin YW, Lee ST, Shin JW, et al. VGKC-complex\/LGI1-antibody encephalitis: clinical manifestations and response to immunotherapy. J Neuroimmunol 265: 75-81, 2013.","DOI":"10.1016\/j.jneuroim.2013.10.005"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Ari\u00f1o H, Armangu\u00e9 T, Petit-Pedrol M, et al. Anti-LGI1-associated cognitive impairment: presentation and long-term outcome. Neurology 87: 759-765, 2016.","DOI":"10.1212\/WNL.0000000000003009"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. van Sonderen A, Petit-Pedrol M, Dalmau J, et al. The value of LGI1, Caspr2 and voltage-gated potassium channel antibodies in encephalitis. Nat Rev Neurol 13: 290-301, 2017.","DOI":"10.1038\/nrneurol.2017.43"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Dubey D, Pittock SJ, McKeon A. Antibody prevalence in epilepsy and encephalopathy score: increased specificity and applicability. Epilepsia 60: 367-369, 2019.","DOI":"10.1111\/epi.14649"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Thompson J, Bi M, Murchison AG, et al. The importance of early immunotherapy in patients with faciobrachial dystonic seizures. Brain 141: 348-356, 2018.","DOI":"10.1093\/brain\/awx323"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/8\/64_4025-24\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T03:29:49Z","timestamp":1745033389000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/8\/64_4025-24\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,15]]},"references-count":10,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.4025-24","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"type":"print","value":"0918-2918"},{"type":"electronic","value":"1349-7235"}],"subject":[],"published":{"date-parts":[[2025,4,15]]},"article-number":"4025-24"}}